Ling Liu
Nanjing, Jiangsu, 210009, China
NCT Number: NCT05207267
A prospective physiologic study, in participants with COVID-19 related or non-COVID-19 related acute respiratory distress syndrome (ARDS) requiring mechanical ventilation less than 48 hours. The investigators assessed the effect of different tidal volume guided by different levels of driving pressure on ventilation inhomogeneity and ventilation/perfusion mismatch by electrical impedance tomography (EIT) in supine and/or prone position.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Nanjing, Jiangsu, 210009, China
Once enrolled, an EIT dedicated belt containing 16 electrodes was placed around the participant's chest at the fifth or sixth intercostal space and connected it to an EIT monitor (PulmoVista 500; Dräger Medical GmbH, Lübeck, Germany).
Data were collected in the enrolled day (Day 1),Day 3 and Day 7 including demographic and anthropometric data, a baseline arterial blood gas measurement, and ventilation parameters including type of supplemental oxygen, respiratory rate, fractional concentration of oxygen in inspired air (FiO2).
Volume control mode without spontaneous breathing, PEEP will be set according to best respiratory compliance method, and tidal volume (VT) will be set to reach three levels of driving pressure (High 14-15cmH2O, moderate 10-11 cmH2O, and low 7-8 cmH2O). Each level of VT was maintained 10 minutes in supine and/or prone position. In the last minutes of each phase,the participants received instructions of end expiratory occlusion lasting at least 10 seconds and, 1 seconds after the start, a bolus of 10 mL of 10% NaCl solution was injected via the central venous catheter. Clinical data and outcome will be collected.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Volume control mode without spontaneous breathing, PEEP will be set according to best respiratory compliance method, and tidal volume (VT) will be set to reach three levels of driving pressure (High 14-15cmH2O, moderate 10-11 cmH2O, and low 7-8 cmH2O). Each level of VT was maintained 10 minutes in supine and/or prone position.
Time frame: Day 1
regional compliance using EIT
Time frame: Day 1
regional ventilation using EIT
Time frame: Day 1
regional perfusion using EIT
Time frame: Day 1
Region-ventilation-delay using EIT
Time frame: Day 3
measurement as one index of respiratory compliance
Time frame: Day 3
regional ventilation measuring by EIT
Time frame: Day 3
regional perfusion measuring by EIT
Time frame: Day 3
the RVD measuring by EIT
Time frame: Day 1
V/Q mismatch was quantified as the percentage of pixels that were classified as ventilated but not perfused (dead space fraction) plus the percentage of those perfused but not ventilated (shunt fraction).
Time frame: Day 3
V/Q mismatch was quantified as the percentage of pixels that were classified as ventilated
Time frame: Day 7
V/Q mismatch was quantified as the percentage of pixels that were classified as ventilated
Time frame: Day 1
higher values indicating less homogenous ventilation
Time frame: Day 3
higher values indicating less homogenous ventilation
Time frame: Day 7
higher values indicating less homogenous ventilation
Time frame: Day 1
PaO2
Time frame: Day 28
ventilation free day in day 28
Time frame: Day 28
death in day 28
Southeast University, China
Other
Safety of Driving Pressure-guided Tidal Volume Setting in ARDS Patients-From the Perspective of EIT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06823804
ARDS, Lung Diseases
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT03764319
ARDS, Acute Lung Injury
Vienna, Austria
View Trial DetailsNCT03793842
ARDS, Acute Respiratory Distress Syndrome
Ann Arbor, Michigan, United States
View Trial DetailsNCT06737432
ARDS, Lung Diseases
Galveston, Texas, United States
View Trial Details